Malaria is a serious global health issue. Artemisinin combination treatments are the first‐line drugs, but supplies are limited because artemisinin is obtained solely by extraction from Artemisia annua. A continuous‐flow process that converts dihydroartemisinic acid into artemisinin (see scheme) was shown to be an inexpensive and scalable process that can ensure a steady, affordable supply of artemisinin
疟疾是一个严重的全球健康问题。
青蒿素联合治疗是一线药物,但供应有限,因为
青蒿素仅从青蒿中提取。将双氢
青蒿酸转化为
青蒿素的连续流动工艺(见方案)被证明是一种廉价且可扩展的工艺,可以确保稳定、负担得起的
青蒿素供应。